French Court Dismisses Genoway's Lawsuit against Cellectis

Genoway had sued Cellectis in January alleging breach of license for a recombinant gene-targeting technology.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories